PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Respiratory Medicine, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo 150-8935, Japan. Electronic address: izumo_takehiro@med.jrc.or.jp.\', \'Department of Respiratory Medicine, Japanese Red Cross Medical Center, 4-1-22 Hiroo, Shibuya-ku, Tokyo 150-8935, Japan.\']
?:citedBy
  • -1
?:creator
?:doi
  • S2212-5345(21)00125-810.1016/j.resinv.2021.07.004
?:doi
?:hasPublicationType
?:journal
  • Respiratory investigation
is ?:pmid of
?:pmid
?:pmid
  • 34413006
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.687
?:rankingScore_hIndex
  • 18
?:title
  • Clinical impact of combination therapy with baricitinib, remdesivir, and dexamethasone in patients with severe COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34413006>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34413006>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all